Cargando…
Calcium Dysregulation in Alzheimer’s Disease: A Target for New Drug Development
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and the most common cause of dementia among aged people whose population is rapidly increasing. AD not only seriously affects the patient’s physical health and quality of life, but also adds a heavy burden to the patient’s family a...
Autores principales: | Wang, Yong, Shi, Yun, Wei, Huafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713908/ https://www.ncbi.nlm.nih.gov/pubmed/29214114 http://dx.doi.org/10.4172/2161-0460.1000374 |
Ejemplares similares
-
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020) -
Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
por: Magi, Simona, et al.
Publicado: (2016) -
Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
por: Galla, Luisa, et al.
Publicado: (2020) -
Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer’s disease
por: Mustaly-Kalimi, Sarah, et al.
Publicado: (2022) -
Calpain Dysregulation in Alzheimer's Disease
por: Ferreira, Adriana
Publicado: (2012)